0001482080-13-000006 Sample Contracts

LICENSE AGREEMENT
Warf Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Wisconsin

This Agreement is made effective the 6th day of June, 2012 ("Effective Date"), by and between the Wisconsin Alumni Research Foundation ("WARF"), a nonprofit Wisconsin corporation, and Cellular Dynamics International, Inc. ("Licensee"), a corporation organized and existing under the laws of Wisconsin.

AutoNDA by SimpleDocs
SUPPLY AGREEMENT
Supply Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • New Jersey

This Supply Agreement (“Supply Agreement”), effective as of July 6, 2010 (“Effective Date”), is by and between Cellular Dynamics International, Inc. (“CDI”) and Hoffmann-La Roche Inc., with an address of 340 Kingsland Street, Nutley New Jersey (“Roche”).

Hepatocyte Collaborative Research Agreement
Hepatocyte Collaborative Research Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • New Jersey

This Collaborative Research Agreement is entered into as of May 16, 2011, (the “Effective Date”) by and between on the one hand, Hoffmann-La Roche Inc. located at 340 Kingsland Street, Nutley, New Jersey 07110 (“Roche”) and, on the other hand, Cellular Dynamics International, Inc. located at 525 Science Drive, Madison, WI 53711 (“CDI”)

1st Amendment
1st Amendment • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)

This Amendment ("Amendment") is made to Distributor Agreement by and between Cellular Dynamics International, Inc. (the "CDI") and iPS Academia Japan, Inc. ("Distributor") dated April 29, 2011 ("Agreement"), and the definitions used in the Agreement shall be also applied to this Amendment.

BACKGROUND
Distributor Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • New York
EXCLUSIVE LICENSE AGREEMENT Between INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION Licensor And CELLULAR DYNAMICS INTERNATIONAL Licensee
Exclusive License Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Indiana

Introduction: This Exclusive License Agreement (“Agreement”) is made and entered into on the Effective Date by and between the Indiana University Research and Technology Corporation., a nonprofit corporation organized under the laws of the state of Indiana, having its principal offices at 351 West 10th Street, Indianapolis, Indiana 46202 (hereinafter “IURTC”), and Cellular Dynamics International, Inc., a corporation organized under the laws of the State of Wisconsin, having its address at 525 Science Drive, Madison, Wisconsin 53711 (hereinafter “CDI”).

SUPPLY AND DISTRIBUTION AGREEMENT
Supply and Distribution Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Delaware

THIS SUPPLY AND DISTRIBUTION AGREEMENT ("Agreement"), dated June 12, 2012 (the "Effective Date"), is entered into between Life Technologies Corporation, a Delaware corporation having a place of business at 5791 Van Allen Way, Carlsbad, California 92008, U.S.A. ("LTC") and Cellular Dynamics International, Inc., a Wisconsin corporation having a place of business at University Research Park, 525 Science Drive, Suite 200, Madison, Wisconsin 53711 ("CDI"). LTC and CDI are sometimes referred to individually as a "Party" or collectively as the "Parties".

AMENDMENT TO LEASE
To Lease • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)

THIS AMENDMENT TO LEASE (“Amendment”) is made as of June 1, 2007, by and between University Research Park, Incorporated, a Wisconsin non-stock corporation (hereinafter referred to as “Landlord”) and Cellular Dynamics International, Inc., a Wisconsin corporation (hereinafter referred to as “Tenant”).

PATENT ASSIGNMENT
Patent Assignment • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)

WHEREAS, James A. Thomson, a U.S. citizen residing in Wisconsin (the “Assignor”), jointly with another co-inventor, owns all right, title, and interest in and to the patent applications listed in the attached Schedule A (the “Assigned Patents”);

First Amendment to Supply and Distribution Agreement
Supply and Distribution Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Delaware

This First Amendment to the Supply and Distribution Agreement (“First Amendment”) is made as of February 27, 2013 (“First Amendment Effective Date”) by and between Life Technologies Corporation, a Delaware corporation with offices at 5791 Van Allen Way, Carlsbad, CA 92008 (“LTC”) and Cellular Dynamics International, Inc., a Wisconsin corporation having a place of business at University Research Park, 525 Science Drive, Suite 200, Madison, Wisconsin 53711 (“CDI”). LTC and CDI are sometimes referred to individually as a “Party” or collectively as “Parties”.

Addendum to MSA Center of Excellence EXECUTION COPY 6/21/2012
Master Laboratory Services Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)

This Addendum is subject to the Master Laboratory Services Agreement effective as November 29, 2010 (“MSA”) between Eli Lilly and Company, an Indiana corporation (“Lilly”), and Cellular Dynamics International Inc., having its principal place of business at University Research Park, 525 Science Drive, Suite 200, Madison, WI 53711 ("CDI") and is made as of the date signed below, and shall be deemed a “Work Order” under the MSA.

GRANT
Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Wisconsin

This Agreement is entered into by and between the Wisconsin Department of Commerce ("Department') and Cellular Dynamics International, Inc., ("Recipient").

Non-Exclusive License Agreement
Non-Exclusive License Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)

This Agreement is made effective as of May 6, 2010 (“Effective Date”) by and between iPS Academia Japan, Inc. (“AJ”), a Japan corporation, with a principal office at 123 Kameya-cho, Kamigyo-ku, Kyoto 602-0854, JAPAN and Cellular Dynamics International, Inc., a Wisconsin corporation, with a principal place of business at 525 Science Drive, Suite 200, Madison, WI 53711, USA (hereinafter referred to as “CDI”). AJ and CDI may be referred to individually as a “Party” or collectively as the “Parties”.

Cellular Dynamics International, Inc. University Research Park Madison, WI 53711 October 18, 2010
Cellular Dynamics International, Inc. • April 10th, 2013 • Biological products, (no disgnostic substances) • Wisconsin

This letter (when executed and delivered by you as contemplated below, “this Agreement”) will confirm terms and conditions upon which you will be employed by Cellular Dynamics International, Inc. (the “Company”). They are as follows:

SUPPLY AGREEMENT
Supply Agreement • April 10th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Wisconsin

This Supply Agreement (“Agreement”), effective as of May 18, 2010 (“Effective Date”), is by and between Cellular Dynamics International, Inc. (“CDI”) and SmithKline Beecham d/b/a GlaxoSmithKline, with an address of five Moore Drive, Research Triangle Park, NC 27709 (“GSK”)(“Customer”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!